Prophylactic and therapeutic efficacy of Acinetobacter phage RMA1 against carbapenem-resistant Acinetobacter baumannii with no cytotoxicity to human skin cells

Puntos clave

• Acinetobacter phage RM_A1 shows therapeutic efficacy against carbapenem-resistant Acinetobacter baumannii infections, and it does not harm human skin cells.
• The study reports no cytotoxicity observed in human skin cells during the treatment with the phage RM_A1.
• Assessment using in vitro methods confirmed the phage's effectiveness without damaging healthy human tissue.
• This highlights the potential of bacteriophages as a novel approach to combat antibiotic-resistant infections without adverse effects.